...
首页> 外文期刊>European Neurology >Excessive Daytime Sleepiness in Idiopathic Restless Legs Syndrome: Characteristics and Evolution under Dopaminergic Treatment
【24h】

Excessive Daytime Sleepiness in Idiopathic Restless Legs Syndrome: Characteristics and Evolution under Dopaminergic Treatment

机译:特发性躁动腿综合征白天过度嗜睡:多巴胺能治疗下的特征和演变

获取原文
获取原文并翻译 | 示例
           

摘要

Background/Aims: Whereas insomnia is frequent in restless legs syndrome (RLS), little is known about daytime sleepiness. We studied a series of 27 consecutive patients with idiopathic RLS in order to identify the characteristics and evolution of excessive daytime sleepiness (EDS) under dopaminergic treatment. Methods: Patients were assessed by clinical examination, questionnaires and video-polysomnography (PSG). Sleepy patients, as defined by Epworth Sleepiness Scale (ESS) >10, were also assessed by the multiple sleep latency test (MSLT). We excluded RLS patients with other sleep-wake disorders, in particular chronic sleep deprivation. Results: Mean age was 56 years, the mean International RLS Study Group Rating Scale score was 24 at baseline. Ten (37%) of the 27 patients reported EDS. RLS patients with sleepiness had a higher amount of total sleep time (p = 0.029) on PSG and a mean sleep latency of 6.4 min on MSLT. No other differences regarding clinical or polysomnographic parameters were found. RLS severity improved in all patients under dopaminergic treatment (p = 0.001); this was also the case for the ESS score in sleepy patients (p = 0.007). Conclusion: In our series of RLS patients, EDS was common, characterized by longer sleep (PSG) and reduced sleep latencies on MSLT. Under dopaminergic treatment, both RLS severity and ESS improved.
机译:背景/目的:尽管不安腿综合征(RLS)失眠多见,但白天嗜睡知之甚少。我们研究了连续的27例特发性RLS患者,以确定多巴胺能治疗下白天过度嗜睡(EDS)的特征和演变。方法:通过临床检查,问卷调查和视频多导睡眠图(PSG)对患者进行评估。还通过多重睡眠潜伏期测试(MSLT)对依爱华氏嗜睡量表(ESS)> 10定义的嗜睡患者进行了评估。我们排除了具有其他睡眠-觉醒障碍,特别是慢性睡眠剥夺的RLS患者。结果:平均年龄为56岁,平均国际RLS研究组评分量表评分为24。 27例患者中有10例(37%)报告了EDS。患有困倦的RLS患者在PSG上的总睡眠时间较长(p = 0.029),而在MSLT上的平均睡眠潜伏期为6.4分钟。没有发现关于临床或多导睡眠图参数的其他差异。所有接受多巴胺能治疗的患者的RLS严重性均得到改善(p = 0.001);昏昏欲睡患者的ESS评分也是如此(p = 0.007)。结论:在我们的一系列RLS患者中,EDS很常见,其特点是睡眠时间更长(PSG)和MSLT的睡眠潜伏期缩短。在多巴胺能治疗下,RLS严重程度和ESS均得到改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号